These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 31477034)

  • 1. Evaluation of the association of Wnt signaling with coronary artery calcification in patients on dialysis with severe secondary hyperparathyroidism.
    Ho TY; Chen NC; Hsu CY; Huang CW; Lee PT; Chou KJ; Fang HC; Chen CL
    BMC Nephrol; 2019 Sep; 20(1):345. PubMed ID: 31477034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the role of severe hyperparathyroidism on coronary artery calcification in dialysis patients.
    Hernandes FR; Barreto FC; Rocha LA; Draibe SA; Canziani ME; Carvalho AB
    Clin Nephrol; 2007 Feb; 67(2):89-95. PubMed ID: 17338428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abdominal aortic calcification score among several vascular calcification scores of plain radiograph is the most reliable predictor of severe coronary artery calcification in dialysis patients.
    Lee SM; Lee HW; Son YK; Kim SE; An WS
    Ren Fail; 2017 Nov; 39(1):729-735. PubMed ID: 29157086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vertebral bone density associates with coronary artery calcification and is an independent predictor of poor outcome in end-stage renal disease patients.
    Chen Z; Qureshi AR; Ripsweden J; Wennberg L; Heimburger O; Lindholm B; Barany P; Haarhaus M; Brismar TB; Stenvinkel P
    Bone; 2016 Nov; 92():50-57. PubMed ID: 27519971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between coronary artery calcification and bone metabolic markers in maintenance hemodialysis patients.
    Xiong L; Chen QQ; Cheng Y; Lan YS; Yang JB; Wen XQ; Xie X; Kang T; Wu WH; Ou S
    BMC Nephrol; 2023 Aug; 24(1):238. PubMed ID: 37582785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of Vascular Calcification and Clinical Outcomes in Patients Receiving Maintenance Dialysis.
    Zhang H; Li G; Yu X; Yang J; Jiang A; Cheng H; Fu J; Liang X; Liu J; Lou J; Wang M; Xing C; Zhang A; Zhang M; Xiao X; Yu C; Wang R; Wang L; Chen Y; Guan T; Peng A; Chen N; Hao C; Liu B; Wang S; Shen D; Jia Z; Liu Z;
    JAMA Netw Open; 2023 May; 6(5):e2310909. PubMed ID: 37126347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of denosumab on cardiovascular calcification in patients with secondary hyperparathyroidism undergoing dialysis: a pilot study.
    Chen CL; Chen NC; Wu FZ; Wu MT
    Osteoporos Int; 2020 Aug; 31(8):1507-1516. PubMed ID: 32246167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of coronary artery calcification and its association with cardiovascular events in patients with chronic kidney disease.
    Wang XR; Yuan L; Shi R; Li H; Wang DG; Wu YG
    Ren Fail; 2021 Dec; 43(1):1172-1179. PubMed ID: 34315328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in bone mineral density after total parathyroidectomy without autotransplantation in the end-stage renal disease patients with secondary hyperparathyroidism.
    Fang L; Wu J; Luo J; Wen P; Xiong M; Cao J; Chen X; Yang J
    BMC Nephrol; 2018 Jun; 19(1):142. PubMed ID: 29907149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deoxycholic Acid, a Metabolite of Circulating Bile Acids, and Coronary Artery Vascular Calcification in CKD.
    Jovanovich A; Isakova T; Block G; Stubbs J; Smits G; Chonchol M; Miyazaki M
    Am J Kidney Dis; 2018 Jan; 71(1):27-34. PubMed ID: 28801122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Parathyroid Hormone Level and Osteoporosis Predict Progression of Coronary Artery Calcification in Patients on Dialysis.
    Malluche HH; Blomquist G; Monier-Faugere MC; Cantor TL; Davenport DL
    J Am Soc Nephrol; 2015 Oct; 26(10):2534-44. PubMed ID: 25838468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications.
    Morena M; Jaussent I; Dupuy AM; Bargnoux AS; Kuster N; Chenine L; Leray-Moragues H; Klouche K; Vernhet H; Canaud B; Cristol JP
    Nephrol Dial Transplant; 2015 Aug; 30(8):1345-56. PubMed ID: 25854266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women.
    Hampson G; Edwards S; Conroy S; Blake GM; Fogelman I; Frost ML
    Bone; 2013 Sep; 56(1):42-7. PubMed ID: 23702386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in association of lower bone mineral density with higher coronary calcification in female and male end-stage renal disease patients.
    Chen Z; Qureshi AR; Brismar TB; Ripsweden J; Haarhaus M; Barany P; Heimburger O; Lindholm B; Stenvinkel P
    BMC Nephrol; 2019 Feb; 20(1):59. PubMed ID: 30777028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Serum Sclerostin Level, Coronary Artery Calcification, and Patient Outcomes in Maintenance Dialysis Patients.
    Ge Y; Wu B; Yu X; Wang N; Xu X; Zeng M; Zhang B; Mao H; Xing C
    Blood Purif; 2022; 51(3):260-269. PubMed ID: 34161949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular calcification progression and its association with mineral and bone disorder in kidney transplant recipients.
    Sun L; Huang Z; Fei S; Ni B; Wang Z; Chen H; Tao J; Han Z; Ju X; Gu M; Tan R
    Ren Fail; 2023; 45(2):2276382. PubMed ID: 37936391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Wnt/β-catenin signalling inhibitors and uraemic vascular calcifications.
    Yang CY; Chang ZF; Chau YP; Chen A; Yang WC; Yang AH; Lee OK
    Nephrol Dial Transplant; 2015 Aug; 30(8):1356-63. PubMed ID: 25817223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive nomogram model for severe coronary artery calcification in end-stage kidney disease patients.
    Tang X; Qian H; Lu S; Huang H; Wang J; Li F; Bian A; Ye X; Yang G; Ma K; Xing C; Xu Y; Zeng M; Wang N
    Ren Fail; 2024 Dec; 46(2):2365393. PubMed ID: 38874139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk factors for coronary artery calcification in patients with end-stage renal disease].
    Cui L; Xu J; Bai Y; Zhang J
    Zhonghua Yi Xue Za Zhi; 2015 Oct; 95(38):3133-7. PubMed ID: 26814105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Denosumab Decreases Epicardial Adipose Tissue Attenuation in Dialysis Patients with Secondary Hyperparathyroidism and Low Bone Mass.
    Chen CL; Liou ES; Wu MT
    Cardiorenal Med; 2024; 14(1):113-122. PubMed ID: 38325352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.